What is CONMED's EV / EBITDA?

CONMED (CNMD) reported EV / EBITDA of 11.7× in Q1 2026.

How has CONMED's EV / EBITDA changed year-over-year?

CONMED's EV / EBITDA decreased by 0.3% year-over-year, from 11.7× to 11.7×.

What is the long-term trend for CONMED's EV / EBITDA?

Over 5 years (2020 to 2025), CONMED's EV / EBITDA has grown at a -19.9% compound annual growth rate (CAGR), from 41.2× to 13.6×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

CONMED CNMD EV / EBITDA

EV / EBITDA at other companies

Johnson & JohnsonJNJ

18.8×+4.2×

StrykerSYK

22.1×-11.8×

Boston ScientificBSX

28.3×-8.5×

VericelVCEL

58.2×-506×

OSI SystemsOSIS

19.6×+5.0×

Zimmer Biomet HoldingsZBH

10.8×-1.4×

Other financials

Income statement

See full

Revenue$317.0M-1.3%

Gross profit$183.4M+3.2%

Operating income$25.4M+59.3%

Net income$13.8M+129%

EPS (diluted)$0.45+137%

Balance sheet

See full

Cash & equivalents$35.0M-1.3%

Total debt$862.6M-3.6%

Total equity$1.0B+4.1%

Total assets$2.3B+0.8%

Cash flow

See full

Operating cash flow$13.5M-67.6%

CapEx$2.9M-23.5%

Free cash flow$10.6M-72.0%

Valuation

See full

Market cap$1.04B-35.6%

Enterprise value$1.87B-24.5%

P/E19×+5.4×

P/S0.8×-0.5×

Profitability

See full

Gross margin55.2%-1.0pp

Operating margin8.2%-5.6pp

Net margin4%-5.0pp

FCF margin9%-3.5pp

Returns & leverage

See full

Return on equity5.5%-7.5pp

Debt / equity0.8×-0.1×

Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

enterprise value/ebitda=11.7×

Based on the most recent quarter.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CONMED's EV / EBITDA?: CONMED (CNMD) reported EV / EBITDA of 11.7× in Q1 2026.
How has CONMED's EV / EBITDA changed year-over-year?: CONMED's EV / EBITDA decreased by 0.3% year-over-year, from 11.7× to 11.7×.
What is the long-term trend for CONMED's EV / EBITDA?: Over 5 years (2020 to 2025), CONMED's EV / EBITDA has grown at a -19.9% compound annual growth rate (CAGR), from 41.2× to 13.6×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.